These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30745845)

  • 21. Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression.
    Li K; Zhang TT; Wang F; Cui B; Zhao CX; Yu JJ; Lv XX; Zhang XW; Yang ZN; Huang B; Li X; Hua F; Hu ZW
    Oncogene; 2018 May; 37(22):2967-2981. PubMed ID: 29520103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. m
    Wu J; Yi T; Zhuo C; Wang D; Zhang M; Hu R; Wu D; Hou G; Xing Y
    J Cell Physiol; 2024 May; 239(5):e31220. PubMed ID: 38372068
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TRIB3 promotes the progression of renal cell carcinoma by upregulating the lipid droplet-associated protein PLIN2.
    Li J; Zhang Q; Guan Y; Liao D; Chen H; Xiong H; Sheng Y; Chen X; Pang J
    Cell Death Dis; 2024 Apr; 15(4):240. PubMed ID: 38561354
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TRIB3-Regulated Akt Signal Pathway Affects Trophoblast Invasion in the Development of Preeclampsia.
    Sui X; Zhang L; Zhang XF; Zhang Y
    Am J Perinatol; 2023 Sep; 40(12):1359-1366. PubMed ID: 34553361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TRIB3 protein denotes a good prognosis in breast cancer patients and is associated with hypoxia sensitivity.
    Wennemers M; Bussink J; Grebenchtchikov N; Sweep FC; Span PN
    Radiother Oncol; 2011 Oct; 101(1):198-202. PubMed ID: 21704407
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIB3 destabilizes tumor suppressor PPARα expression through ubiquitin-mediated proteasome degradation in acute myeloid leukemia.
    Luo X; Zhong L; Yu L; Xiong L; Dan W; Li J; Ye J; Chu X; Liu C; Liu B
    Life Sci; 2020 Sep; 257():118021. PubMed ID: 32621919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRIB3 promotes MYC-associated lymphoma development through suppression of UBE3B-mediated MYC degradation.
    Li K; Wang F; Yang ZN; Zhang TT; Yuan YF; Zhao CX; Yeerjiang Z; Cui B; Hua F; Lv XX; Zhang XW; Yu JJ; Liu SS; Yu JM; Shang S; Xiao Y; Hu ZW
    Nat Commun; 2020 Dec; 11(1):6316. PubMed ID: 33298911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tripping on TRIB3 at the junction of health, metabolic dysfunction and cancer.
    Mondal D; Mathur A; Chandra PK
    Biochimie; 2016 May; 124():34-52. PubMed ID: 26855171
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion.
    Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q
    Front Immunol; 2023; 14():1290839. PubMed ID: 38235126
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tribble 3, a novel oxidized low-density lipoprotein-inducible gene, is induced via the activating transcription factor 4-C/EBP homologous protein pathway.
    Shang YY; Zhong M; Zhang LP; Guo ZX; Wang ZH; Zhang Y; Deng JT; Zhang W
    Clin Exp Pharmacol Physiol; 2010 Jan; 37(1):51-5. PubMed ID: 19566842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pseudokinase TRIB3 controls adipocyte lipid homeostasis and proliferation in vitro and in vivo.
    Hernández-Quiles M; Martinez Campesino L; Morris I; Ilyas Z; Reynolds S; Soon Tan N; Sobrevals Alcaraz P; Stigter ECA; Varga Á; Varga J; van Es R; Vos H; Wilson HL; Kiss-Toth E; Kalkhoven E
    Mol Metab; 2023 Dec; 78():101829. PubMed ID: 38445671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circ-APBB1IP as a Prognostic Biomarker Promotes Clear Cell Renal Cell Carcinoma Progression Through The ERK1/2 Signaling Pathway.
    Mo J; Zhao Y; Ao Z; Chen L; Lin S; Zeng W; Wu H; Liu J
    Int J Med Sci; 2020; 17(9):1177-1186. PubMed ID: 32547313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The mammalian tribbles homolog TRIB3, glucose homeostasis, and cardiovascular diseases.
    Prudente S; Sesti G; Pandolfi A; Andreozzi F; Consoli A; Trischitta V
    Endocr Rev; 2012 Aug; 33(4):526-46. PubMed ID: 22577090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Deletion of TRIB3 disrupts the tumor progression induced by integrin αvβ3 in lung cancer.
    Zhou W; Ma J; Meng L; Liu D; Chen J
    BMC Cancer; 2022 Apr; 22(1):459. PubMed ID: 35473511
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TRIB3 promotes malignancy of head and neck squamous cell carcinoma via inhibiting ferroptosis.
    Chen L; Lin W; Zhang H; Geng S; Le Z; Wan F; Huang Q; Chen H; Liu X; Lu JJ; Kong L
    Cell Death Dis; 2024 Mar; 15(3):178. PubMed ID: 38429254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The long non-coding RNA FOXD2-AS1 promotes bladder cancer progression and recurrence through a positive feedback loop with Akt and E2F1.
    Su F; He W; Chen C; Liu M; Liu H; Xue F; Bi J; Xu D; Zhao Y; Huang J; Lin T; Jiang C
    Cell Death Dis; 2018 Feb; 9(2):233. PubMed ID: 29445134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High Annexin A5 expression promotes tumor progression and poor prognosis in renal cell carcinoma.
    Tang J; Qin Z; Han P; Wang W; Yang C; Xu Z; Li R; Liu B; Qin C; Wang Z; Tang M; Zhang W
    Int J Oncol; 2017 May; 50(5):1839-1847. PubMed ID: 28393205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ.
    Zhou S; Liu S; Lin C; Li Y; Ye L; Wu X; Jian Y; Dai Y; Ouyang Y; Zhao L; Liu M; Song L; Xi M
    Oncogene; 2020 Apr; 39(18):3710-3725. PubMed ID: 32157210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TRIB3 promotes oral squamous cell carcinoma cell proliferation by activating the AKT signaling pathway.
    Shen P; Zhang TY; Wang SY
    Exp Ther Med; 2021 Apr; 21(4):313. PubMed ID: 33717256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.